28/09/2025
Multiple Sclerosis (MS) is one of the most debilitating autoimmunity-related disorders affecting approximately 2.4 million people worldwide. MS mainly affects young adults between the second and fourth decades of life. Its high prevalence, early onset and impact on quality of life have led to a significant increase in research on MS in recent decades.
Recently, there has been a focus on modifiable factors that increase the risk or facilitate disease progression. Within this scenario, sleep seems to have a direct or indirect relationship with many factors related to the etiopathogenesis of MS, confirming the presence of marked sleep disorders throughout the disease.
The close indirect relationship between sleep and MS is based on mutual immune, inflammatory, and neurodegenerative mechanisms.
Sleep disorders are more frequent in MS patients than in controls, in particular: insomnia, obstructive sleep apnoea and restless leg syndrome.
Additional factors that link sleep to MS include: quality of life, the emotional sphere (e.g. anxiety and depression), and certain MS-related conditions that impact sleep (e.g. pain and nocturia).
Based on recent scientific evidence, possible new sleep-based therapeutic scenarios (sleep hygiene, CBT, melatonin and vitamin D) are possible therapeutic treatments for the numerous MS patients who complain of sleep disorders.
https://www.sciencedirect.com/science/article/pii/S1568997225001636?via%3Dihub